John O’Quigley

7.8k total citations · 1 hit paper
133 papers, 5.3k citations indexed

About

John O’Quigley is a scholar working on Statistics and Probability, Management Science and Operations Research and Economics and Econometrics. According to data from OpenAlex, John O’Quigley has authored 133 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Statistics and Probability, 40 papers in Management Science and Operations Research and 21 papers in Economics and Econometrics. Recurrent topics in John O’Quigley's work include Statistical Methods in Clinical Trials (70 papers), Optimal Experimental Design Methods (39 papers) and Statistical Methods and Inference (36 papers). John O’Quigley is often cited by papers focused on Statistical Methods in Clinical Trials (70 papers), Optimal Experimental Design Methods (39 papers) and Statistical Methods and Inference (36 papers). John O’Quigley collaborates with scholars based in France, United States and United Kingdom. John O’Quigley's co-authors include Lloyd D. Fisher, Margaret S. Pepe, Alexia Iasonos, Larry Z. Shen, Mark R. Conaway, Janez Stare, Nolan A. Wages, Sarah Zohar, Xavier Paolettí and John T. Kent and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

John O’Quigley

128 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer

1990 1.0k citations John O’Quigley et al. Biometrics profile →

Peers

Countries citing papers authored by John O’Quigley

Since Specialization

Citations

This map shows the geographic impact of John O’Quigley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John O’Quigley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John O’Quigley more than expected).

Fields of papers citing papers by John O’Quigley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John O’Quigley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John O’Quigley. The network helps show where John O’Quigley may publish in the future.

Co-authorship network of co-authors of John O’Quigley

This figure shows the co-authorship network connecting the top 25 collaborators of John O’Quigley. A scholar is included among the top collaborators of John O’Quigley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John O’Quigley. John O’Quigley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of early phase dose finding algorithms in heterogeneous populations 2023 ·Journal of Statistical Planning and Inference ·(unknown), Alexia Iasonos, John O’Quigley	0
2	Stopping rules for phase I clinical trials with dose expansion cohorts 2021 ·Statistical Methods in Medical Research ·Sean M. Devlin, Alexia Iasonos, John O’Quigley	3
3	Dose Transition Pathways: The Missing Link Between Complex Dose-Finding Designs and Simple Decision-Making 2017 ·Clinical Cancer Research ·Christina Yap, Lucinda Billingham, Ying Kuen Cheung, Charles Craddock, John O’Quigley	21
4	Faulty BRCA1, BRCA2 genes: how poor is the prognosis? 2017 ·Annals of Epidemiology ·John O’Quigley	1
5	Phase I/II dose-finding, safety and efficacy study of radium-223 dichloride in renal cell carcinoma patients with bone metastases 2016 ·Annals of Oncology ·Réza Elaidi, Yann Vano, Nicolas Aide, Laure Fournier, Désirèe Deandreis, Florence Tenenbaum, Rachida Lebtahi, (unknown), Laurence Albigès, Bernard Escudier, Florence Joly, J. Alexandre, Michela Bernardini, Stéphanie Baron, Julia Arfi‐Rouche, Cory V. Noel, (unknown), John O’Quigley, Jacques Médioni, Stéphane Oudard	36
6	The Impact of Non–Drug-Related Toxicities on the Estimation of the Maximum Tolerated Dose in Phase I Trials 2012 ·Clinical Cancer Research ·Alexia Iasonos, Mrinal M. Gounder, David R. Spriggs, John F. Gerecitano, David M. Hyman, Sarah Zohar, John O’Quigley	13
7	Obtaining the Optimal Dose in Alcohol Dependence Studies 2012 ·Frontiers in Psychiatry ·Nolan A. Wages, Lei Liu, John O’Quigley, Bankole A. Johnson	2
8	An approach to meta‐analysis of dose‐finding studies 2011 ·Statistics in Medicine ·Sarah Zohar, Sandrine Katsahian, John O’Quigley	12
9	Posterior maximization and averaging for Bayesian working model choice in the continual reassessment method 2011 ·Statistics in Medicine ·Takashi Daimon, Sarah Zohar, John O’Quigley	11
10	Optimal designs for estimating the most successful dose 2006 ·Statistics in Medicine ·Sarah Zohar, John O’Quigley	18
11	Quantification of the Prentice Criteria for Surrogate Endpoints 2006 ·Biometrics ·John O’Quigley, Philippe Flandre	10
12	Retrospective Analysis of Sequential Dose‐Finding Designs 2005 ·Biometrics ·John O’Quigley	14
13	Explained randomness in proportional hazards models 2004 ·Statistics in Medicine ·John O’Quigley, Ronghui Xu, Janez Stare	117
14	Continual Reassessment Method for Ordered Groups 2003 ·Biometrics ·John O’Quigley, Xavier Paolettí	61
15	Proportional hazards models with frailties and random effects 2002 ·Statistics in Medicine ·John O’Quigley, Janez Stare	72
16	Dose-Finding Designs for HIV Studies 2001 ·Biometrics ·John O’Quigley, Michael D. Hughes, Terry Fenton	98
17	Integral evaluation for continual reassessment method 1994 ·Computer Methods and Programs in Biomedicine ·(unknown), John O’Quigley	3
18	A Geometric Interpretation of Partial Correlation Using Spherical Triangles 1993 ·The American Statistician ·(unknown), John O’Quigley	10
19	Methods for dose finding studies in cancer clinical trials: A review and results of a monte carlo study 1991 ·Statistics in Medicine ·John O’Quigley, Sylvie Chevret	111
20	Gynecological abnormalities following allogeneic bone marrow transplantation. 1990 ·PubMed ·(unknown), Keith M. Sullivan, Mark M. Schubert, Janet Nims, (unknown), Jean E. Sanders, John O’Quigley, Robert P. Witherspoon, CD Buckner, Rainer Storb	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact